Bank of New York Mellon’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-178,826
Closed -$12.4M 4193
2024
Q3
$12.4M Sell
178,826
-39,345
-18% -$2.7M ﹤0.01% 1819
2024
Q2
$14.7M Buy
218,171
+23,460
+12% +$1.58M ﹤0.01% 1753
2024
Q1
$13.4M Sell
194,711
-23,505
-11% -$1.59M ﹤0.01% 1813
2023
Q4
$13.6M Buy
218,216
+4,258
+2% +$238K ﹤0.01% 1809
2023
Q3
$12M Buy
213,958
+303
+0.1% +$17K ﹤0.01% 1834
2023
Q2
$10.8M Sell
213,655
-3,608
-2% -$192K ﹤0.01% 1917
2023
Q1
$11.9M Sell
217,263
-5,338
-2% -$312K ﹤0.01% 1840
2022
Q4
$13.9M Sell
222,601
-12,675
-5% -$841K ﹤0.01% 1749
2022
Q3
$16.6M Buy
235,276
+25,030
+12% +$1.73M ﹤0.01% 1607
2022
Q2
$11.9M Buy
210,246
+762
+0.4% +$41.8K ﹤0.01% 1833
2022
Q1
$13.1M Buy
209,484
+2,038
+1% +$110K ﹤0.01% 1929
2021
Q4
$11.6M Buy
207,446
+11,174
+6% +$683K ﹤0.01% 2025
2021
Q3
$12.8M Buy
196,272
+49,243
+33% +$3.36M ﹤0.01% 1989
2021
Q2
$9.32M Buy
147,029
+39,249
+36% +$2.32M ﹤0.01% 2178
2021
Q1
$6.46M Sell
107,780
-4,993
-4% -$271K ﹤0.01% 2327
2020
Q4
$5.63M Sell
112,773
-17,523
-13% -$823K ﹤0.01% 2305
2020
Q3
$6.65M Buy
130,296
+18,858
+17% +$787K ﹤0.01% 2073
2020
Q2
$3.91M Buy
111,438
+39,057
+54% +$1.35M ﹤0.01% 2334
2020
Q1
$1.84M Buy
72,381
+7,163
+11% +$213K ﹤0.01% 2592
2019
Q4
$1.81M Sell
65,218
-10,022
-13% -$239K ﹤0.01% 2873
2019
Q3
$2.02M Sell
75,240
-729
-1% -$25.4K ﹤0.01% 2751
2019
Q2
$3.11M Buy
75,969
+50,293
+196% +$1.41M ﹤0.01% 2566
2019
Q1
$615K Buy
+25,676
New +$466K ﹤0.01% 3449

Other funds holding AXNX

Bank of New York Mellon's AXNX Position: Q4 2024 in Review

Bank of New York Mellon sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 178,826 shares — an estimated $12.4M sold.

Bank of New York Mellon first reported a position in AXNX in Q1 2019 and held it in 23 quarters. The position peaked at $16.6M in Q3 2022. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Bank of New York Mellon reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 178,826 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $12.4M.
  • Bank of New York Mellon first reported a position in Axonics, Inc. Common Stock in Q1 2019 and held it in 23 quarters.
  • Bank of New York Mellon's Axonics, Inc. Common Stock position peaked at $16.6M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Bank of New York Mellon's 13F filing for Q4 2024, filed 4 Feb 2025.